ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Metisa Metalurgica Timboense Sa

Metisa Metalurgica Timboense Sa (MTSA3)

77.275
0.00
(0.00%)
Closed January 22 2:55PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
77.275
Bid
0.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
78.25 52 Week Range 78.95
Market Cap
Previous Close
77.275
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
4,212,530
Dividend Yield
5.56%
PE Ratio
3.79
Earnings Per Share (EPS)
20.72
Revenue
654.85M
Net Profit
87.28M

About Metisa Metalurgica Timboense Sa

Sector
Farm Machinery And Equipment
Industry
Farm Machinery And Equipment
Headquarters
Timbo, Santa Catarina, Bra
Founded
-
Metisa Metalurgica Timboense Sa is listed in the Farm Machinery And Equipment sector of the Brazil Bovespa Exchange with ticker MTSA3. The last closing price for METISA ON was R$77.28. Over the last year, METISA ON shares have traded in a share price range of R$ 78.25 to R$ 78.95.

METISA ON currently has 4,212,530 shares outstanding. The market capitalization of METISA ON is R$325.52 million. METISA ON has a price to earnings ratio (PE ratio) of 3.79.

MTSA3 Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
52-1.675-2.121595946878.9578.9578.2515078.68333333CS
1567.27510.39285714297078.9569.2317873.499375CS
26042.275120.7857142863578.9532.9928850.30591837CS

MTSA3 - Frequently Asked Questions (FAQ)

What is the current METISA ON share price?
The current share price of METISA ON is R$ 77.275
How many METISA ON shares are in issue?
METISA ON has 4,212,530 shares in issue
What is the market cap of METISA ON?
The market capitalisation of METISA ON is BRL 325.52M
What is the 1 year trading range for METISA ON share price?
METISA ON has traded in the range of R$ 78.25 to R$ 78.95 during the past year
What is the PE ratio of METISA ON?
The price to earnings ratio of METISA ON is 3.79
What is the cash to sales ratio of METISA ON?
The cash to sales ratio of METISA ON is 0.51
What is the reporting currency for METISA ON?
METISA ON reports financial results in BRL
What is the latest annual turnover for METISA ON?
The latest annual turnover of METISA ON is BRL 654.85M
What is the latest annual profit for METISA ON?
The latest annual profit of METISA ON is BRL 87.28M
What is the registered address of METISA ON?
The registered address for METISA ON is RUA FRITZ LORENZ 2442 CAIXA POSTAL 11 BAIRRO DTTO. INDUSTRI, TIMBO, SANTA CATARINA, 89120-000
What is the METISA ON website address?
The website address for METISA ON is www.metisa.com.br
Which industry sector does METISA ON operate in?
METISA ON operates in the FARM MACHINERY AND EQUIPMENT sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ZAMP3Zamp S.A.
R$ 2.94
(14.40%)
992.1k
OPCT3Oceanpact Servicos Maritimos S.A
R$ 5.59
(12.93%)
4.56M
AZEV11Azevedo Travassos Sa
R$ 0.29
(11.54%)
28.7k
ONCO3Oncoclinicas Brasil Servicos Medico
R$ 2.22
(8.82%)
11.99M
AZUL4AZUL SA
R$ 4.60
(6.98%)
24.08M
AMAR11Lojas Marisa S.A.
R$ 0.47
(-14.55%)
3.2k
BSLI4Banco De Brasilia SA
R$ 7.20
(-9.32%)
600
PGMN11Empreendimentos Pague Menos S.A.
R$ 0.51
(-8.93%)
14.5k
RCSL3Recrusul Sa
R$ 4.20
(-8.89%)
4.66M
OIBR4Oi
R$ 8.61
(-8.60%)
86.3k
HAPV3Hapvida Participacoes Investimento SA
R$ 2.31
(1.32%)
55.24M
ABEV3Ambev SA
R$ 11.02
(-2.04%)
44.99M
BBDC4Bco Bradesco Sa
R$ 11.48
(-1.37%)
42.53M
VALE3Vale SA
R$ 52.66
(-2.52%)
34.65M
CVCB3CVC Brasil Operadora E Agencia De Viagens SA
R$ 1.84
(6.36%)
32.57M

Discussion

View Full Feed
vinmantoo vinmantoo 6 minutes ago
Jq1234, give Bluesky a try. It looks a lot like Twitter did but doesn’t have a controlling algorithm.
WhAtEvA1 WhAtEvA1 6 minutes ago
With 18 indications trial starting in India well ahead of US trials (and if proven successful) it won't take long when Vivos valuations will be trading forward. IMHO of course. It is worth bios do when efficacy data is strong and potential of approval in the public interest outweighs the risks.
RDGL
glens0 glens0 7 minutes ago
$CTOR Not to many shares left in the market. Should go up real fast when good news comes out. And it should be soon.
Total Insider Shares Held 64.72M
Citius Oncology Annual Shares Outstanding
(Millions of Shares)
2024 68M
CTOR
Zorch305 Zorch305 8 minutes ago
Whats 305
RNVA
theorysuit theorysuit 9 minutes ago
You keep pointing to this journal as if that leads to approval. I think i told you this, this journal was meant to explain this garbage trial.....Pointing to the scoreboard. Any approvals? Over 20 years since this trial was started, 6 years since it has ended, and 4.5 years since data lock. NO
NWBO
WHITTENHALLJR WHITTENHALLJR 9 minutes ago
Yes I bet it 2x better then before strap in stock-nuts
CLHI
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 10 minutes ago
Anavex Life Sciences Corp. AVXL: This clinical stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.8% over the last 60 days. Anavex’s shares gained 63.3% over the last three months compared with the S&P 500’s adva
AVXL
GUNSMOKE GUNSMOKE 10 minutes ago
https://www.otcmarkets.com/filing/html?id=18121280&guid=sJ0-kqxrs0Hhh3h
ASST
band aid band aid 10 minutes ago
Bobby, he or she is saying that this is a PIG. I wish you good luck here and I hope you hit it out of the park. As for me I took a huge pounding on this trash but still hold a small position just in case the sky falls out of the universe and this PIG could figure out a way to sell some of their jun
BIEL
glens0 glens0 11 minutes ago
CTOR Not to many shares left in the market. Should go up real fast when good news comes out.
Total Insider Shares Held 64.72M
Citius Oncology Annual Shares Outstanding
(Millions of Shares)
2024 68M
CTOR
NoMoDo NoMoDo 12 minutes ago
Done. He is an amazing boy. Nuclear engineer.
HMBL
Acme Investments Acme Investments 12 minutes ago
👇 When he comes through it will be something else for you clowns to talk about!! Sitting around counting days is Sad!!
BCAP
Whalatane Whalatane 13 minutes ago
Recent Open Market purchases by the Chairman of the Board ...David Mott
On December 19, 2024, Mott purchased 213,300 shares at an average price of $4.6722, for a total amount of $996,58034.
On November 13, 2024, he bought 215,868 shares at an average price of $4.6167, totaling $996,59
ARDX
Carjockey2 Carjockey2 13 minutes ago
You don't have to apologize to anybody certainly not me!!!

Family always is first.

Thank him for his Service is the only thing I would ask you to do from me.

$HMBL
HMBL
IAMNOTWALTAH IAMNOTWALTAH 13 minutes ago
I-Glow and Threefight are just two sides of the same coin, it’s just two people bashing and pumping without any actual concrete information and being vague when you ask them for actual proof by saying they heard stuff through the “grapevine” or copy and pasting the same paragraph they have been post
AVVH
janice shell janice shell 15 minutes ago
Default occurs when a party does nothing. That is what Megan will do. The SEC will request a default judgment, and it will be granted by the judge.

Megan won't pay up, and that will be the end.
boi568 boi568 15 minutes ago
First, this is technically only a guideline addressing FDA staff involved in the approval process. However, the effect of the guidance unavoidably impacts the results for companies submitting NDAs in early AD. That's why all the more formal rulemaking procedural elements are being applied; it's bei
AVXL
jobynimble jobynimble 17 minutes ago
KRTL Holding Group Inc. Announces Milestone Achievement: FDA Registration of Industria Químico Farmaceutica SIGMA CORP. S.R.L.’s Federal Establishment Identifier
January 22, 2025 09:00 ET

Source: KRTL Holding Group

Lakewood, CO, Jan. 22, 2025 (GLOBE NEWSWIRE) --
KRTL
biotechinvestor1 biotechinvestor1 18 minutes ago
Inconsequential. The UK decision has to do with Herceptin SC and Mabthera SC. Back then Roche did not file RHUPH20 as an active ingredient early in the process. So the court is saying that they should have done so from the beginning of their filing. Since then everyone has learned their lessons. 
HALO
JimmyTwoTimes JimmyTwoTimes 18 minutes ago
https://media4.giphy.com/media/kIVVupOM0VoW3bNuU7/giphy.gif?cid=6c09b952a8wkvsa7qrmsfrgtjsk2td2p9pidwjk21v4yg2om&ep=v1_internal_gif_by_id&rid=giphy.gif&ct=g
OWPC

Your Recent History

Delayed Upgrade Clock